StockNews.com Upgrades Aptose Biosciences (NASDAQ:APTO) to Hold

StockNews.com upgraded shares of Aptose Biosciences (NASDAQ:APTO – Free Report) (TSE:APS) from a sell rating to a hold rating in a report released on Tuesday. APTO has been the topic of a number of other reports. Piper Sandler reissued an overweight rating and issued a $5.00 price target on shares of Aptose Biosciences in a […]

Related Keywords

Texas ,United States ,Canada ,Piper Sandler ,Aptose Biosciences ,Sigma Planning Corp ,Canaccord Genuity Group ,Texas Capital Bank Wealth Management Services Inc ,Annandale Capital ,Aptose Biosciences Inc ,Free Report ,Genuity Group ,Moderate Buy ,Get Free Report ,Planning Corp ,Biosciences Inc ,Aptose Biosciences Daily ,